Form 4: DENTSPLY SIRONA CEO Scavilla Boosts Equity Holdings

Sentiment:

Insider Transaction Report


DENTSPLY SIRONA Inc. CEO Daniel T. Scavilla acquired 245.816 shares of common stock through RSU dividends, increasing his direct beneficial ownership.

Summary

  • Daniel T. Scavilla, President, CEO, and Director of DENTSPLY SIRONA Inc. (XRAY), acquired 245.816 shares of common stock.
  • The acquisition occurred on January 9, 2026, and represents dividends on previously awarded Restricted Stock Units (RSUs).
  • These additional RSUs are subject to the same vesting terms as the underlying awards and vest simultaneously.
  • Each RSU converts to common stock on a 1:1 basis.
  • Following this transaction, Scavilla directly beneficially owns 17,944.546 shares of DENTSPLY SIRONA Inc. common stock.

Sentiment

Score: 6

Explanation: Slightly positive due to increased insider ownership, even if through routine RSU dividends, indicating continued alignment with shareholder interests.

Positives

  • Increased alignment between management and shareholder interests as the CEO's equity stake grows.
  • The acquisition of shares through RSU dividends indicates a routine compensation component, reinforcing long-term incentive structures.

Negatives

  • The acquisition was not a direct cash purchase by the CEO, but rather a dividend on existing equity awards, meaning no new capital was invested by the insider.

Future Outlook

This Form 4 filing does not contain forward-looking statements or guidance.

Industry Context

This routine insider transaction does not provide specific insights into broader industry trends or competitors. It reflects standard executive compensation practices within publicly traded companies.

Stakeholder Impact

  • Shareholders may view the increased insider ownership as a positive sign of management's commitment and alignment with long-term company performance.

Key Dates

DateDescription
01/09/2026Date of transaction (acquisition of common stock)
01/13/2026Date Form 4 was signed by Attorney-in-Fact

Recommendation

hold

This Form 4 filing details a routine acquisition of shares by the CEO through RSU dividends, which is a standard part of executive compensation. While it increases insider ownership and aligns management interests with shareholders, it does not represent a new cash investment by the insider or provide new fundamental information to warrant a change in investment recommendation based solely on this filing.

Keywords

DENTSPLY SIRONA, XRAY, Daniel T. Scavilla, Insider Trading, Form 4, SEC Filing, Restricted Stock Units, RSU Dividends, Beneficial Ownership, CEO, Director

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.